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Abstract
Purpose: The aim of our work is to evaluate results obtained from a cohort of patients affected by periprosthetic joint
infection and treated with a primary cementless stem in a two-stage technique framework. Methods: Eighty-four patients
were evaluated at a mean follow-up of 37.4 months. The main demographic, surgical, clinical, and radiographic data were
recorded. A femoral window for stem removal was performed in 33 patients. Results: Statistically significant
improvement was noted for both the Harris Hip score and the Oxford Hip score. Postsurgical complications included
thigh pain in three patients, subsidence (>2 mm) in one patient, implant dislocation in two patients, cup revision in one
patient, implant revision for septic failure in two patients, and stem revision for varus position in one patient. The stem
survivorship rate was 96.3%. There were no significant differences between the groups in which a cortical window was
created or not. Conclusion: Femoral stem revision with primary cementless stems is a viable option in selected patients
undergoing two-stage hip revision surgery. Correct indication is a cornerstone of good outcome. The use of a cortical
window does not affect the final outcome or implant survivorship rate.
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Introduction
Data from orthopedic registries show that the number of
total hip replacements is increasing,1–3 particularly among
middle-aged patients (<55 years)4 and older healthy patients
with elevated functional demands. Hip implant revisions
have risen in parallel, posing considerable challenges to
orthopedic surgeons.5 Infection accounts for about 17.5%
of reasons for revision surgery.1 Periprosthetic joint infec-
tion (PJI) has become increasingly common and a frequent
cause of multiple revisions, resulting in diminished quality
of life for patients and higher costs for society.3 Surgical
solutions for chronic PJI are one- or two-stage revision with
the use of interim antibiotic-loaded cements spacers or
beads. Both approaches provided good results even in com-
plex cases.6–10
Surgeons performing revision hip arthroplasty will pay
scrupulous attention to both the acetabular and the femoral
aspects, particularly the latter, to achieve adequate primary
stability with a stem implant that provides fixation as prox-
imal as possible and as distal as necessary.11 In this way,
the proximal portion of the femur can be loaded to help
preserve diaphyseal bone stock in the event of future revi-
sion reconstructions. With careful preoperative surgical
planning and optimal patient selection, femoral revision
with primary stems may offer a valid alternative.
1Ortopedia e Traumatologia II, Azienda Ospedaliera Santa Corona, Pietra
Ligure (SV), Italy
2Clinica Ortopedica, Ospedale Policlinico San Martino, Genova, Italy
Corresponding author:
Luca Cavagnaro, Ortopedia e Traumatologia II, Azienda Ospedaliera Santa
Corona, Via XXV Aprile 38, 17027 Pietra Ligure (SV), Italy.
Email: cavagnaro.luca@libero.it
Journal of Orthopaedic Surgery
27(2) 1–8







Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons
Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial
use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open
Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
The use of primary stems for revision surgery is not new.
Early attempts were burdened by aseptic implant loosening
in 44% of patients at 4.5 years.12 The shift to cemented
stems was equally unsuccessful, and failure rates were
unacceptably high. Encouraged by the good outcomes with
primary cementless stems, several authors obtained optimal
mid-to-long-term results with cementless stems with distal
anchorage.13–17 Although good results with primary
cementless stems have recently been reported, most of the
case series are highly heterogeneous and often include
patients with aseptic implant loosening.
The aim of the present study was to evaluate the clinical
and radiographic mid-term outcomes after two-stage hip revi-
sion for PJI in which the femoral component was exchanged
with a primary cementless stem. Specifically, we wanted to
(1) evaluate the feasibility of two-stage hip revision with
primary cementless stems; (2) identify a patient subgroup
with PJI that could benefit from primary stem implantation;
and (3) determine whether cortical fenestration has an effect
on the outcome in these patients.
Methods
The study protocol was approved by the local institutional
review board. Informed consent was obtained from
patients prior to surgery. The data were collected from the
prospective institutional arthroplasty registry. We
reviewed the clinical and radiographic data of 86 patients
(86 hips) who underwent two-stage femoral revision with a
primary cementless stem for PJI between March 2010 and
June 2017. In the same time period, we treated 136 hip PJI.
Of these 86 patients, 84 were assessed at the final follow-
up and 2 had died of causes unrelated to surgery during the
follow-up period. Two types of stems were used the CLS
Spotorno stem (Zimmer-Biomet, Warsaw, Indianna, USA)
and the Wagner Conus stem (Zimmer-Biomet). The CLS
Spotorno stem has a 3-D wedge shape and a trapezoidal
cross section; it comes in two versions, one with a caput–
collum–diaphyseal (CCD) angle of 125 and the other with
a CCD angle of 135 for different anatomical configura-
tions.18 The Wagner Conus also comes in two versions
(CCD 125 and 135) with eight longitudinal ribs for rota-
tional stability.19 Both implants are made from a special
titanium alloy (Protasul-64), which, by virtue of its grit-
blasted surface, promotes osseointegration of the entire
stem.
Inclusion criteria were definitive diagnosis of PJI accord-
ing to Musculoskeletal Infection Society criteria,20 having
completed two-stage revision with a primary cementless
stem, minimum of 6 months since surgery. Exclusion criteria
were one-stage revision, implant loosening, and not having
completed two-stage revision. PJI were classified according
to Tsukayama.21 Patients were examined before surgery,
during the period between stages to evaluate the develop-
ment of sepsis, at 3, 6, and 12 months after revision surgery,
and then yearly thereafter. Demographic data (age, sex, body
mass index, and serious comorbidities) were recorded.
Microbiological isolates obtained before and during surgery
were identified. Surgical data included type of stem
removed, number of previous surgeries, type of bone defect
according to the Paprosky classification,22 use or not of
acetabular spacer,23 type of femoral spacer (long stemmed
or short stemmed), creation or not of a cortical window for
stem removal, length and degree of integration, operating
time for stem removal and implantation, mean time between
the first and the second stage, type of stem, and collar used
for revision. Clinical evaluation was based on changes in the
Harris Hip score (HHS) and Oxford Hip score (OHS) before
revision and then at follow-up. The HHS measures func-
tional ability, hip dynamics, and range of movement on scale
from 0 to100 (with higher scores indicating better function)
as excellent (90), good (89–90), moderate (79–70), and
poor (<70). Thigh pain was also assessed. Radiographic
parameters included leg length discrepancy (LLD), subsi-
dence > 2 mm (calculated as the increase in distance
between the apex of the great trochanter and the most lateral
side of the stem shoulder between the immediate postopera-
tive period and the last follow-up evaluation), signs of
implant loosening, osteolysis in the Gruen zones,24 defined
as new, expansive radiotransparent lesions not present in the
immediate postoperative period, stem in varus or valgus
position (>5 mm from the anatomical femoral axis), and
cortical hypertrophy or heterotrophic calcification according
to Brooker’s classification. LLD was calculated using a line
tangent to both ischium bones as a landmark of the pelvis
position. The two parallel lines crossing the tip of the lesser
trochanter of each femur, respectively, were used to measure
LLD. In addition, the horizontal offset of the healthy side
was calculated by comparing it with the treated side on
completion of the procedure. Radiographs were evaluated
independently by two orthopedic surgeons expert in septic
revision. In case of disagreement, the definitive decision was
made by collegial evaluation. Complications arising during
the two surgical stages, during the period between the stages,
and during follow-up were evaluated and recorded. For com-
parison of outcomes, the patients were subdivided into two
groups: one with and the other without a cortical window.
Surgical technique and postoperative
management
Patients were operated through the posterolateral approach;
the implant was removed in a standard fashion.23 A lateral
cortical window was created for stem removal in 33 patients
(Figure 1). Fenestration was performed in cases in which
endofemoral removal of the stem was unsuccessful. In 66
cases, a femoral spacer (Tecres, Sommacampagna (VR),
Italy) was used together with a custom-made acetabular
spacer in the bone cement with antibiotic (Palacos® R þ
gentamicin, Heraeus Medical, Wehrheim, Germany).
A short-stem femoral spacer was used in 46 cases and a
long-stem spacer in the remaining 38. The choice of definitive
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stem type was based on preoperative planning and intraopera-
tive evaluation of the surgical field, which can be done only
after removal of the spacer and meticulous debridement. Dur-
ing revision implantation, six biopsies were taken for culture
and one sample was obtained for intraoperative frozen section
histology and definitive histology. A double mobility cup
was used in 23 patients to prevent postoperative instability
or dislocation. A drain was maintained in place until post-
operative day 2. Patients were mobilized starting on day 2
with partial weight-bearing (50% body weight). Thrombo-
prophylaxis with low-molecular-weight heparin and elastic
compression stockings was continued until full weight-
bearing. Antibiotic therapy was continued based on the
sensitivity of pathogens isolated from intra and postopera-
tive samples.
Statistical analysis
Continuous variables are expressed as the mean + standard
deviation and were compared using Student’s t-test for
dependent and independent data. Categorical variables are
expressed as the number of cases or percentage. A p value
of <0.05 was considered statistically significant. Associa-
tions were evaluated using Fisher’s exact test. Implant sur-
vivorship was estimated using Kaplan–Meier analysis. The
interobserver concordance was calculated using Cohen’s
kappa.
Results
All patients were classified as having late-onset PJI. Table 1
presents the main demographic and surgical data. Comorbid
conditions included diabetes in nine patients, rheumatoid
arthritis in four patients (two of which with diabetes), sub-
stance use in four patients, cardiac disease in three patients,
active neoplasia in three patients, and chronic renal insuffi-
ciency in two patients (one of which with systemic lupus
erythematosus). Seventeen patients were smokers (10
Figure 1. (a) Creation of a cortical window with an orthopedic bone saw, (b) femoral window with anterior-based periosteal flap,
(c) the cortical window is lifted with an osteotome, and (d) white arrow indicating stem exposure of the underlying.





Age (years), mean + SD 63.8 + 16.2
BMI (kg/m2), mean + SD 26.1 + 3.6
Femoral bone defects according to
Paprosky classification, n (%)
Type I 37 (44.0)
Type II 44 (52.4)
Type IIIA 3 (3.6)
Revised stem, n (%)
Standard cementless 69 (82.1)
Ministem cementless 11 (13.1)
Standard cemented 2 (2.4)
Revision cementless 2 (2.4)
Previous surgeries (n), mean + SD 2.5 + 1.1
Length of femoral cortical window (cm),
mean + SD
5.1 + 2.9
Surgical time at first stage (min), mean + SD 102.3 + 34.1
Interstage time (weeks), mean + SD 13.6 + 4.8
Surgical time at second stage (min), mean + SD 82.0 + 26.5
Final stem, n (%)
CLS 63 (91.3)
Wagner Conus 6 (8.7)
BMI: body mass index; SD: standard deviation.
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cigarettes per day). The mean follow-up was 37.4 + 19.7
months. Baseline microbiological data are presented in
Figure 2. Two patients were implanted with a revision
cementless stem, that is, two cases of de-escalation
(Figure 3). Consolidation of the cortical window was
completed at revision implantation (Figure 4); however,
dislocation of a fragment occurred in 5 cases and radio-
graphic persistence of the osteotomy lines, with intraopera-
tive stability of the cortical fragment, was noted in 18 cases.
The primary stem was combined with a custom-made cup in
nine patients with severe acetabular bone defects. A Trilogy
Trabecular Acetabular system (Zimmer-Biomet) was
implanted in the remaining cases.
There was a statistically significant improvement in the
HHS from 41.7 + 9.1 before to 90.8 + 4.8 after surgery and
a change in OHS from 22.9 + 4 to 42.5 + 3.8. All patients
but one reported excellent or good results. Three patients
reported thigh pain at follow-up assessment, in one of which
cortical fenestration was performed. Radiographic follow-up
showed no cases of implant migration or loosening. Seven
patients presented with further areas of osteolysis in Gruen
zone 1. No other cases of cortical hypertrophy occurred.
Heterotrophic ossification was observed in six cases: four
type I, one type II, and one type III. Postoperative radio-
graphic LLD was 2.1 + 3.9 mm in one patient with sub-
sidence >2 mm. Three implants were classified as varus (one
Figure 2. Microbiological isolates. CoNS: coagulase-negative staphylococci; MSSA: methicillin-sensitive Staphylococcus aureus;
MRSA: methicillin-resistant S. aureus; Gram: gram negative.
Figure 3. Radiographic analysis of a case of therapeutic de-escalation. A 36-year-old man with a history of acetabular fracture treated
with fixation and a PJI with MSSA. (a) Preoperative plain film; (b) immediate postoperative plain film showing long femoral spacer,
acetabular spacer in place, and cortical window; and (c) control plain film at 3 months, note the good healing of the femoral window.
Plain film at 1 year 2 months of follow-up showing a CLS primary stem. PJI: periprosthetic joint infection; MSSA: methicillin-sensitive
Staphylococcus aureus.
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of which in a patient with subsidence) and one as varus. In 16
of the 84 cases (19.0%), the new stem extended the point of
the previous femoral stem: the distal extension of the new
stem was equal to or less than that of the previous stem. The
mean horizontal offset was 54.3 + 5.8 mm on the healthy
side and 63.1 + 7.8 mm on the operated side, with offset
maintained or lateralized in all patients.
No complications during stem removal occurred. During
the interstage period, spacer dislocation occurred in four
patients, femoral spacer fracture in one patient, and fixation
with cerclage wires of a greater trochanter fracture in one
patient. No fractures occurred during the interstage interval.
One Wagner Conus stem was revised on postoperative day 5
because of extensive varus positioning and was replaced
with the same type of stem. Cup revision was performed
on postoperative day 7 in one patient because of excessive
inclination. Dislocation occurred in one patient 1 month
postoperative; the dislocation was resolved with noninvasive
treatment. Repeated dislocation occurred in 1 patient: opti-
mal mid-term outcome was achieved with reoperation with
substitution of the implant cup. Neither of these patients had
been implanted with a double mobility cup. Two cases of
implant failure due to infection occurred a fungal infection
(Candida tropicalis) in one patient was successfully resolved
with a second two-stage revision. In the other patient, a
smoker and substance abuser, methicillin-resistant Staphylo-
coccus aureus was isolated. A second two-stage revision was
carried out but, because of persistent infection, a Gidlerstone
resection arthroplasty was performed. No other specific or
general complications were recorded. The total revision
complications rate was 7.1%, and the Kaplan–Meier func-
tion showed a stem survival rate of 96.3%, considering as
end point stem revision for any cause (Figure 5). Evaluation
of patients with and those without a cortical window showed
fairly comparable results at the final follow-up examination.
The main differences are highlighted in Table 2. Statistically
significant differences between the two groups were found
for operating time for stem removal and new stem implanta-
tion. The interobserver correlations for the radiographic vari-
ables were 0.95 for subsidence, 0.91 for implant loosening,
0.83 for osteolysis, 0.89 for heterotrophic calcification, 0.96
for cortical hypertrophy, 0.92 for stem malposition, and 0.87
for LLD, with nearly complete concordance between the two
surgeons.
Discussion
It is a common opinion that in hip revisions, the femoral
stem should extend past the femoral bone defect by at least
double the cortical diameter25; however, this is not borne out
by the literature. Strict adherence to this idea would result in
Figure 4. Radiographic follow-up of stem removal by means of cortical window technique. (a) Preoperative plain film, AP view of
femoral spacer immediately after implantation, (b) white arrows indicate osteotomy lines, and (c) evaluation at 4 months after spacer
implantation showing good healing of the cortical window. Radiograph at 27 months of follow-up showing well-positioned CLS stem and
consolidation of the femoral window. AP: anteroposterior.
Figure 5. The Kaplan–Meier survival function for stem revision
for any reason (n 84) in patients treated with two-stage revision
managed with primary cementless stems.
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overtreatment and further damage to the femoral bone stock.
The aim of the present study was to analyze the data from a
cohort of patients treated with a two-stage femoral revision
with a primary stem. The secondary outcomes were to (1)
identify the preoperative criteria for selection of patients
potentially eligible for this type of revision and (2) determine
whether fenestration for stem removal can affect this type of
approach. Our study is the first to date that describes this
type of approach in a homogeneous group of patients treated
with two-stage revision for PJI.
In 2014, Tetreault et al.26 published their results after
hip revision with a primary stem in the largest cohort
treated up to then with this technique. A total of 144
patients were evaluated after 4-year follow-up to deter-
mine the percentage of revisions (Paprosky femoral bone
defect types I and IIIA) that could benefit from primary
stem implantation. Fifty-four cases were septic revisions,
but the authors did not specify which technique they had
used. Despite the optimal clinical outcomes and osseoin-
tegration of the stem in 96% of cases, there was a 9.8%
re-revision rate of the femoral component, with intrao-
perative fracture in five patients, postoperative fracture
in three patients, and implant dislocation in eight patients.
Half of the patients were implanted with a primary stem.
Consistent with our observations, the authors reported that
the new stem need not extend beyond the point of the
previous stem. Comparison of our data with the literature
shows that our results are comparable with, if not better
than, the average.
Globally, 63% of patients treated in the considered time
period were managed with primary stems. The remainders
were not suitable for this treatment mainly for the presence
of massive bone defect that jeopardize the primary stem
stability.
The use of primary stems in femoral revision is not
new. In 1987, Pierre Vivès et al. developed the concept
of de-escalation—replacement of a locked long stem with
a primary stem.27 In 2012, Miletic et al.28 reported the
mid-term outcomes with this technique: 15 patients under-
went locked long-stem revision with a standard stem and
femorotomy for stem removal was performed in all cases.
Based on the optimal outcomes and 100% stem survivor-
ship, the authors concluded that the technique could be
considered reliable. Furthermore, as demonstrated also by
our data, femoral fenestration does not affect the surgical
outcome.
The problem of therapeutic escalation in revision arthro-
plasty was mentioned also by Pinaroli et al.29; the aim of
their study was to identify a subgroup of patients under-
going hip revision who could potentially benefit from the
use of a primary stem. Their results are comparable with
ours and share our concepts of revision and patient selec-
tion. But because only 6 of the 41 patients included in their
study were classified as septic and 4 were treated with a
two-stage revision, the conclusions we can draw about this
patient subgroup are necessarily weak.
Tauber and Kidron30 were the first to experiment with
the press-fit CLS Spotorno cementless stem in hip revision.
They implanted the stem in 24 patients (one of which sep-
tic) and obtained satisfactory mid-term results (96%
implant survivorship), particularly when the trochanteric
bone stock could be preserved. Other authors obtained dif-
ferent results with this approach using proximally hydro-
xyapatite (HA)-coated primary cementless stems. In 2006,
Kelly et al.31 published the results obtained in 33 revisions
(six of which septic) using partially HA-coated stems. They
reported that the main factors to be considered in revision
with a primary stem are the presence of good diaphyseal
Table 2. The two groups are substantially homogeneous. a
Characteristic No cortical window Cortical window p Value
Age (years) 59 + 15.1 63.8 + 13.7 0.412
Femoral bone defects according to Paprosky classification, n —
Type I 22 15 —
Type II 27 17 —
Type IIIA 2 1 —
BMI (kg/m2) 25.8 + 2.6 26.3 + 3.3 0.652
Surgical time at first stage (min) 95.8 + 20.3 121.8 + 38.9 <0.05
Surgical time at second stage (min) 77.1 + 24.4 93.0 + 23.4 <0.05
HHS at final follow-up 92.2 + 4.4 88.6 + 3.5 0.404
OHS at final follow-up 44.1 + 2.7 40.8 + 3.1 0.375
Thigh pain, n 2 1 1
Subsidence, n — 1 0.393
Varus stems, n 2 1 1
Valgus stems, n 1 — 1
LLD (mm) 1.4 + 3.8 2.7 + 4.3 0.186
Complications rate (%) 8.7 4.2 0.523
BMI: body mass index; HHS: Harris Hip score; OHS: Oxford Hip score; LLD: leg length discrepancy; SD: standard deviation.
aThere were no remarkable differences in main clinical and radiographic outcomes, except for surgical time. Statistically significant differences are given
in boldface. Values are represented as mean + SD, unless otherwise specified.
6 Journal of Orthopaedic Surgery 27(2)
bone stock of the lesser trochanter and at least 4 cm of
diaphyseal bone at the bone–prosthesis interface. Follow-
ing these criteria, the authors observed optimal osseointe-
gration of the implant at 60 months of follow-up and a 91%
stem survivorship rate (three septic failures). While our
data support the need for good metaphyseal bone stock,
they are contrary to the need for so large a diaphyseal
engagement, as demonstrated by the optimal results
obtained in patients with femoral osteotomy. Two years
later, Salemyr et al.32 published their data on 62 aseptic
revisions with another type of partially coated stem.
Despite the 95% implant survivorship rate, excellent or
good results were obtained in only 38.3% of patients. The
authors also reported a high local complications rate: thigh
pain in 13.3% of patients and stem subsidence in 19
patients. More recently, Khanuja et al.33 reported results
of revision in 19 patients, 15 of which septic, treated with
a two-stage revision with a proximally HA-coated cement-
less stem. Despite the small patient sample, the authors
stated that this type of stem may be a valid surgical choice
for treating patients with type I and type II Paprosky
femoral bone defect. These observations are shared by
Thorey et al.34 in their study published in 2008 that
reported the data on 79 revisions with an uncemented par-
tially HA-coated primary stem at a mean follow-up of
6.8 years. Again, few firm conclusions can be drawn from
such a small patient subgroup.
The complications rate in our study is in line with more
recent studies.35 The patient in whom the stem was
replaced due to varus positioning had a history of acute
bilateral epiphysiolysis treated with minimal fixation and
osteotomy for femoral reorientation in four previous inter-
ventions. In one of the patients with implant dislocation, the
underlying cause was fracture of the proximal epiphysis of
femur and three previous interventions; the other patient
had a Paprosky bone defect type IIIA, previous revision for
repeated dislocation, plate fixation of femoral peripros-
thetic fracture, and five previous interventions.
As pointed out by Gastaud et al.36, these situations
emphasize the importance of accurate patient selection.
We share their observation that patient selection hinges
on meticulous evaluation of bone deficiency; however,
we differ in the opinion that cortical fenestration does not
affect good surgical outcome.
Our study has several limitations. The retrospective design
and short medium-term follow-up may constitute a bias in our
conclusions. Nonetheless, the study’s strong points are the
homogeneous patient cohort, the systematic evaluation of
primary stems in septic patients, and the comparison between
patients with and without a cortical window.
Conclusion
Based on our data, we can state that femoral revision with
primary cementless stems may be considered a valid option
in a subgroup of patients undergoing two-stage revision for
PJI. Preoperative criteria for achieving good surgical out-
come are moderate femoral bone defect (Paprosky type I or
II), a low number of previous interventions (two or less),
and a previous cementless femoral stem. When these cri-
teria are followed, de-escalation may be considered if nec-
essary. Lastly, in cases where needed, cortical fenestration
does not affect the clinical outcome or the implant survi-
vorship rate.
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